ACM
BIIB icon

Alta Capital Management’s Biogen BIIB Stock Holding History

Alta Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,568
Closed -$812K – 90
2020
Q1 		$812K Buy
2,568
+1,284
+100% +$390K 0.04% 69
2019
Q4 		$381K Hold
1,284
– – 0.02% 72
2019
Q3 		$298K Hold
1,284
– – 0.02% 76
2019
Q2 		$300K Hold
1,284
– – 0.02% 79
2019
Q1 		$303K Sell
1,284
-250
-16% -$78.7K 0.02% 76
2018
Q4 		$461K Sell
1,534
-130
-8% -$41.5K 0.03% 66
2018
Q3 		$587K Hold
1,664
– – 0.03% 63
2018
Q2 		$482K Sell
1,664
-216
-11% -$60.7K 0.03% 61
2018
Q1 		$514K Hold
1,880
– – 0.03% 59
2017
Q4 		$598K Hold
1,880
– – 0.04% 57
2017
Q3 		$588K Hold
1,880
– – 0.04% 58
2017
Q2 		$510K Buy
1,880
+15
+0.8% +$3.97K 0.03% 61
2017
Q1 		$509K Sell
1,865
-24
-1% -$6.79K 0.03% 62
2016
Q4 		$535K Hold
1,889
– – 0.04% 65
2016
Q3 		$591K Sell
1,889
-40,635
-96% -$12M 0.04% 64
2016
Q2 		$10.3M Buy
42,524
+1,412
+3% +$372K 0.63% 44
2016
Q1 		$10.7M Buy
41,112
+25,317
+160% +$6.69M 0.66% 43
2015
Q4 		$4.84M Buy
15,795
+1,539
+11% +$442K 0.39% 42
2015
Q3 		$4.16M Buy
14,256
+1,242
+10% +$410K 0.35% 45
2015
Q2 		$5.26M Buy
13,014
+947
+8% +$380K 0.43% 44
2015
Q1 		$5.09M Buy
12,067
+10,466
+654% +$4.13M 0.43% 44
2014
Q4 		$543K Hold
1,601
– – 0.05% 69
2014
Q3 		$529K Hold
1,601
– – 0.05% 66
2014
Q2 		$504K Buy
1,601
+19
+1% +$5.72K 0.05% 70
2014
Q1 		$483K Hold
1,582
– – 0.05% 70
2013
Q4 		$442K Hold
1,582
– – 0.05% 66
2013
Q3 		$380K Hold
1,582
– – 0.05% 67
2013
Q2 		$340K Buy
+1,582
New +$338K 0.05% 67

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alta Capital Management's BIIB Position: Q2 2020 in Review

Alta Capital Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 2,568 shares — an estimated $812K sold.

Alta Capital Management first reported a position in BIIB in Q2 2013 and held it in 28 quarters. The position peaked at $10.7M in Q1 2016. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Alta Capital Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Alta Capital Management sold 2,568 Biogen shares in Q2 2020, an estimated $812K.
  • Alta Capital Management first reported a position in Biogen in Q2 2013 and held it in 28 quarters.
  • Alta Capital Management's Biogen position peaked at $10.7M in Q1 2016.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Alta Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.